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The enpp ectonucleotidases regulate lipidic and purinergic signalling pathways by controlling
the extracellular concentrations of purines and bioactive lipids. Although both pathways are
key regulators of kidney physiology and linked to human renal pathologies, their roles during
nephrogenesis remain poorly understood. We previously showed that the pronephros was a
major site of enpp expression and now demonstrate an unsuspected role for the conserved
vertebrate enpp4 protein during kidney formation in Xenopus. Enpp4 over-expression results
in ectopic renal tissues and, on rare occasion, complete mini-duplication of the entire kidney.
Enpp4 is required and sufficient for pronephric markers expression and regulates the
expression of RA, Notch and Wnt pathway members. Enpp4 is a membrane protein that
binds, without hydrolyzing, phosphatidylserine and its effects are mediated by the receptor
s1pr5, although not via the generation of S1P. Finally, we propose a novel and non-catalytic
mechanism by which lipidic signalling regulates nephrogenesis.
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Vertebrate kidney organogenesis is orchestrated bynumerous signalling pathways and transcription factorsregulating the proliferation and differentiation of diverse
cell types to form the functional kidney. Despite the differences in
complexity and organization of the three vertebrate kidneys,
pronephros, mesonephros and metanephros, there is a remark-
able conservation of molecular mechanisms during their
development1. The pronephros, the functional embryonic kidney
in amphibians, is a simple, easily accessible organ, which displays
structural similarities to the other more complex kidney forms.
Therefore, it has become an ideal model system to study mole-
cular regulation during nephrogenesis and renal pathologies2–5.
In mammals, lipidic and purinergic pathways regulate meta-
nephric physiology and their deregulation has been linked to
acute renal injury and chronic kidney diseases including renal
fibrosis polycystic kidney disease, renal cell carcinoma, nephritis
or diabetic nephropathy6–10. However, their potential roles dur-
ing renal development have not been fully established, although
the bioactive lipid sphingosine-1-phosphate (S1P) has been
implicated during kidney branching11. Purines, mostly ATP and
its derivatives, and bioactive lipids, S1P and lysophosphatidic acid
(LPA), can function as extracellular ligands for G protein-coupled
cell surface receptors12,13. Their availability for these receptors, in
the extracellular space, is regulated by the activities of several
membrane-bound enzymes, such as the ectonucleotidases, which
are major regulators of renal health and disease10,14. The enpp
(ectophosphodiesterase/nucleotide phosphohydrolase) proteins,
which belong to the ectonucleotidase subfamily, are key reg-
ulators of both purinergic and lipidic signalling pathways with
their dual enzymatic activities of hydrolysing purines and gen-
erating S1P and LPA bioactive lipids15. We have demonstrated
that the pronephros is the major site of expression for the
amphibian enpp genes family, in particular, enpp4 is highly
expressed in Xenopus laevis pronephric tubules16. These data
provided the first temporal and spatial embryonic expression
profile for this evolutionally conserved enzyme which remains
functionally poorly understood17–19. In the present study, we
investigated the function of enpp4 during pronephric
development.
We demonstrate that Enpp4 function is crucial during kidney
formation. While its knock-down leads to kidney formation
defects, the overexpression of wild-type Enpp4, but not an inac-
tive enzymatic protein, induces the formation of ectopic prone-
phroi characterized mostly by the presence of proximal tubule
markers but in rare occasion of more distal tubule markers. These
effects are mediated by the lipidic receptor S1pr5 and we also
show that Enpp4 specifically binds to phosphatidylserine,
implying a role for bioactive lipids in pronephrogenesis. Finally,
we provide evidence that enpp4 misexpression alters the expres-
sion of members of the Notch, Wnt and RA signalling pathways
and we propose a model for the mechanisms of action for Enpp4
and lipidic signalling in kidney development.
Results
Overexpression of Enpp4 results in ectopic pronephric tubules
formation. To analyse potential functional roles of Enpp4 during
pronephros development, we first undertook a gain of function
approach by performing immunostaining with pronephric
tubules specific antibodies20 on stage 41 embryos (Fig. 1a–o, and
Supplementary Table 1 for raw data and statistical analyses).
Enpp4 overexpression altered proximal pronephric tubules for-
mation, in nearly 50% of the analysed embryos and induced
ectopic (23%) and enlarged (18%) regions of the 3G8 staining
domain (n= 91, Fig. 1b–e; Supplementary Table 1). Distal
tubules were less affected, with 31% of the analysed embryos
displaying abnormal 4A6 staining. Ectopic 4A6 staining was rare
(2%), with enlarged more distal tubule staining being the pre-
dominant phenotype (20%). Enpp4-induced phenotypes are sig-
nificantly different compared to those of LacZ controls (3G8:
p < 0.001 and 4A6: p < 0.05). Ectopic pronephroi were observed
only when injections were performed into regions fated to
become the lateral region of embryos (V2 blastomere) (Supple-
mentary Fig. 1a). Enpp4 overexpressing embryos displaying
ectopic 3G8 staining (n= 5) were analysed by transverse section.
Eight of the nine ectopic tubules sectioned had epithelial tubule
structure complete with a lumen (Fig. 1f–j), which were similar to
normal pronephric tubule structure (Fig. 1k, l). Similar significant
renal phenotypes were observed following mouse Enpp4 mRNA
injection (p < 0.001, n= 63; Fig. 1m). However, no ectopic pro-
nephric tubules were observed upon overexpression of Enpp4
mutant constructs containing a point mutation in the putative
catalytic domain (T72A, T72S) or metal cation binding domain
(D36N, D189N) (Fig. 1n, o)16. These data suggest that ectopic
proximal pronephric tissues formation caused by Enpp4 over-
expression depends on its catalytic activity.
Overexpression of Enpp4 disturbs proximal-distal patterning
of pronephros. To further investigate this phenotype, embryos
injected with enpp4 mRNA were examined at stage 37 by whole-
mount in situ hybridization using pronephric specific markers,
slc5a1.1, slc12a1, clcnkb and gata3, which mark the various
proximal/distal tubule segments21,22 (Fig. 1a and p–s, see also
Supplementary Table 1). Interestingly, Enpp4 overexpressing
embryos showed ectopic and enlarged staining of slc5a1.1
(proximal tubule marker, ectopic 30%, enlarged 14%; n= 57;
p < 0.001) and slc12a1 (marker of intermediate tubules, ectopic
17%, enlarged 25%; n= 57, p < 0.001) domains (Fig. 1p–q).
Injection of enpp4 mRNA failed to induce any separate ectopic
clcnkb expression although the normal domain of expression
(intermediate and distal tubule) was somewhat enlarged on the
injected side (19%, n= 58, p < 0.01; Fig. 1r). The gata3 expression
domain (distal and collecting tubules) was relatively normal,
although its anterior limit of expression, determined relative to
the somite number, was slightly more posterior in more than half
of the injected embryos (58%, n= 43, p < 0.001; Fig. 1s). This
might reflect a change in anterior/posterior patterning induced by
Enpp4 overexpression.
Injection of enpp4 mRNA induced enlarged and reduced
expression domains of both glomus marker wt1 and nphs1 at
stage 33/34 but ectopic glomus staining was only observed in rare
cases (Fig. 1t–u; Supplementary Table 1a). Although the statistical
significance of these phenotypes was demonstrated (Supplemen-
tary Table 1b), we were not able to conclude on the exact Enpp4
effects on this structure.
Taken together, the results demonstrate that enpp4 mRNA
injection altered pronephros formation, leading to enlarged
expression domains of markers of the entire tubule segments
and to ectopic pronephric structures containing mostly domains
of proximal and, in rare occasions, distal tubules marker genes.
Overexpression of Enpp4 upregulates early kidney markers
expression without altering mesoderm formation. Embryos
injected with enpp4 mRNA were also examined by whole-mount
in situ hybridization using early pronephros anlagen markers
irx1, lhx1, pax823,24 and compared to lacZ mRNA injected
embryos (see Supplementary Table 1). At stage 28, expression of
both lhx1 (61%, n= 51) and pax8 (70%, n= 50) was significantly
(p < 0.001) expanded especially in posterior parts of pronephric
anlagen, with areas of intense staining consistent with that of the
more anterior presumptive tubules (Fig. 1v–w). At early neurula
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stages (Fig. 1x–y), the expansion of pax8 (17%, n= 70) expression
domain was also observed (Fig. 1y). Furthermore, ectopic pax8
expression was also induced following enpp4 RNA injection at
both stages analysed (neurula stage, 21%; stage 28, 2%; p < 0.001;
Supplementary Table 1b). Lhx1 expression was also altered at
early neural stages, but no ectopic lhx1 expression was observed
(Fig. 1x, Supplementary Table 1b). Furthermore, irx1 expression
domain was not altered following Enpp4 overexpression (Sup-
plementary Fig. 1b).
Since normal somite development is a prerequisite for
pronephros development, enpp4 RNA injected embryos were
analysed by whole-mount in situ hybridization using the muscle
marker myh4 at stage 33/34. The expression pattern was normal
in all injected embryos (n= 55; Supplementary Fig. 1c; Supple-
mentary Table 1). Enpp4 overexpression did not also alter the
expression of pan-mesoderm marker, xbra at stage 10.5 (n= 46;
Supplementary Fig. 1d and Supplementary Table 1). Therefore,
we conclude that, enpp4 mRNA injection had no gross effects on
mesoderm induction per se or on somite development.
Morpholino knock-down of enpp4 results in smaller prone-
phros formation. To determine whether Enpp4 is required for
normal pronephros development, we have undertaken a loss of
function approach using two specific anti-sense morpholino oli-
gonucleotides (MOs) (Fig. 2, Supplementary Fig. 2a–c for speci-
ficity and efficiency of the MOs and Supplementary Table 2). The
overall morphology of the embryos appeared normal in enpp4
morphants. Moreover, the expression pattern of the somitic
myh4, muscle myoD and early mesoderm xbra markers was
unaffected in enpp4 MO1 injected embryos (myh4 100%, n= 47
and xbra 84%, n= 19; Supplementary Fig. 2d, e) suggesting that
Fig. 1 Overexpression of enpp4 induces ectopic proximal pronephric tubules. a Schematic diagram of pronephric structural components showing the
expression domain for each marker used in this study, adapted from ref. 21. G: glomus, PT: proximal tubule, IT: intermediate tubule, DT: distal tubule, CT:
collecting tubule. b–y Embryos injected with 2 ng of enpp4 and 250 pg of LacZ mRNAs were examined by 3G8/4A6 antibody staining (b–o) or whole-
mount in situ hybridization with the following probes: slc5a1.1 (p), slc12a1 (q), clcnkb (r) and gata3 (s) at stage 37/38; wt1 (t) and nphs1 (u) at stage 32; lhx1
(v, x) and pax8 (w, y) at stages 28 and 14. f–l Transverse sections of the embryo shown in panels (d) and (e) were cut in the anterior–posterior registers
indicated by lines in panel (e). A higher magnification image (i) of ectopic pronephros in the somite indicated by square in (f) and of control kidney (k) and
counterstained with Hoechst to indicate nuclei (j, l). Embryos injected with 2 ng of mouse wild-type Enpp4 (m), X. laevis mutated in the putative catalytic
site (n) or in the cation binding site (o) and 250 pg of LacZmRNAs were examined by 3G8/4A6 antibody staining. The asterisk denotes the uninjected side
of each embryo. Arrowheads indicate ectopic marker staining. Blank arrowheads in (s) indicate the anterior limit of gata3 expression. See also
Supplementary Table 1 for raw data and statistical analyses and Supplementary Fig. 1.
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any kidney phenotypes observed in enpp4 morphants are not due
to general mesoderm defects.
Injection of enpp4 MO1 resulted in a significant reduction of
expression of both 3G8 (65%, p < 0.001) and 4A6 (28%, p < 0.05)
(n= 107, Fig. 2a, b, Supplementary Table 2), indicating that a
smaller pronephros had formed. A similar phenotype was
observed following enpp4 MO2 injection (3G8 49%, 4A6 24%,
n= 87; Supplementary Fig. 2f, g) and was worsened when both
MO were injected together (Fig. 2c). These results indicate that
Enpp4 is required for both proximal and distal pronephric tubule
development.
Enpp4 knock-down in embryos showed a significant reduced
expression of slc5a1.1 (58%, n= 64, p < 0.001) and slc12a1 (56%,
n= 75, p < 0.01) with MO1 (Fig. 2d, e) as well as with MO2
(Supplementary Fig. 2h, i). Rescue experiments performed by co-
injecting mouse Enpp4 mRNA (2 ng) with enpp4 MO1 or MO2
(10 ng each, n= 72 or 28, respectively) restore partially but
significantly (p < 0.001) the normal phenotype of slc12a1 staining
domain confirming the specificity of the knock-down of enpp4
expression on pronephric development (Fig. 2f and Supplementary
Fig. 2j). Ectopic slc12a1 expression was also observed in some
embryos (11% and 50% with MO1 or MO2, respectively)
consistent with Enpp4 overexpression phenotype. The clcnkb
expression in the intermediate tubules and gata3 anterior
expression domain were reduced after enpp4 MO1 (53.5%,
n= 40 and 31%, n= 42, respectively) but these differences are
not statistically significant p > 0.05) (Fig. 2g, h). Enpp4 knock-down
has no effect on glomus formation, as the expression of wt1 and
nphs1 was normal in most of enpp4MO1 injected embryos at stage
33/34 (wt1= 94%, n= 34 and nphs1= 83%, n= 41) (Fig. 2i, j).
These results suggest that enpp4 knock-down affected pronephric
tubule, especially proximal and intermediate segments, differentia-
tion rather than just the proximal-distal patterning of pronephric
tubule segmentation.
To address potential Enpp4 roles during early phases of
pronephros development, we tested by RT-PCR its expression at
key stages during kidney development in dissected developing
pronephric tissues (Fig. 3a). At later stages, enpp4 expression
profile is in agreement with our published in situ hybridization
data16. However, weak expression is also detected in the
embryonic kidney from stage 12.5 and is upregulated by stage
26. These data suggest that Enpp4 might be involved during early
pronephric developmental phases. The expression domain of lhx1
and pax8 was altered following knock-down of enpp4 by MO
injection (see Supplementary Table 2 for raw data and statistical
analyses). At stage 28, expression of lhx1 was reduced especially
in posterior elements of the pronephric anlagen (35%, n= 23;
Fig. 2k), although its expression in presumptive proximal tubules
was sometimes unaffected or expanded. At stage 24, the
expression domain of lhx1 was clearly reduced (75%, n= 20,
Fig. 2l), suggesting involvement of Enpp4 in early pronephros
differentiation. Injection of enpp4 MO2 caused similar pheno-
types at both stages (stage 28, 30%, n= 20; stage 24, 55%, n= 20;
Supplementary Fig. 2k–l). At early neurula stages, expression of
lhx1 was also reduced following enpp4 MO1 or MO2 injection
(MO1 37%, n= 46; MO2 64%, n= 61; p < 0.001; see also
Supplementary Table 2) and even absent after MO1 injection
(MO1 31%, n= 46) (Fig. 2m and Supplementary Fig. 2m). The
injection of both MO’s resulted in a stronger reduction of lhx1
expression (n= 31; Fig. 2n). A reduction of pax8 expression was
also observed at the neurula stages following enpp4 MO1 or MO2
injection (Fig. 2o and Supplementary Fig. 2n).
Fig. 2 MO knock-down of enpp4 expression disrupts pronephros formation. Embryos targeted with 10 ng of enpp4 MO1 or 10 ng of both enpp4 MOs
(c, n) and 250 pg of lacZ mRNA were examined by 3G8/4A6 antibody staining (a–c) or whole-mount in situ hybridization with the following probes:
slc5a1.1 (d), slc12a1 (e, f), clcnkb (g) and gata3 (h) at stage 37/38; wt1 (i) and nphs1 (j) at stage 33/34, lhx1 (k–n) at stages 28, 24 and 14, pax8 (o) at stage
14. The embryo shown in (f) was co-injected with 2 ng of mouse Enpp4 mRNA to rescue enpp4 knock-down phenotype. The asterisk denotes the control,
uninjected side of each embryo. Blank arrowheads in (h) indicate the anterior limit of gata3 expression. See also Supplementary Table 2 for raw data and
statistical analyses and Supplementary Figs. 2 and 3.
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Taken together, the Enpp4 knock-down and rescue experi-
ments demonstrate that normal levels of enpp4 expression are
required for normal pronephric development.
Enpp4 misexpression phenotypes are distinct from those fol-
lowing enpp6 misexpression. To address if the ectonucleotidase
Enpp6, also expressed in the proximal pronephric tubules16, can
compensate for Enpp4 loss of function, we performed single or
double enpp4/enpp6 knock-down and rescue experiments (Sup-
plementary Fig. 3 and Supplementary Table 2). Enpp6 depletion
induced the formation of a smaller pronephros on the injected
side, in the similar frequency than enpp4 knock-down
(Supplementary Fig. 3b, c). The co-injection of enpp4 MO2 and
enpp6 MO resulted in the formation of reduced 3G8 (64%,
n= 76) and 4A6 (62%, n= 76) positive tissues and was not sta-
tistically different from the effects of enpp4 MO2, demonstrating
that the enpp6 MO did not worsen the renal phenotype caused by
enpp4 knock-down (Supplementary Fig. 3a). Pronephric forma-
tion was altered following Enpp6 overexpression, with reduced or
absent, but never ectopic, pronephros observed and injection of
enpp6 mRNA did not rescue the enpp4 MO2 phenotype (Sup-
plementary Fig. 3d, e). Taken together, these data suggest that
there is no functional redundancy between Enpp4 and Enpp6
ectonucleotidases.
Fig. 3 The enpp and the lipidic receptors, the lpar and s1pr, gene family members are expressed in the pronephros. Developing pronephric anlagen or
pronephric tubules were dissected as indicated, from whole X. laevis embryos and total RNA extracted. RT-PCR was performed on pronephric dissected
tissues and control whole embryos along with negative and linearity controls. a Comparative expression pattern of the enpp genes and pronephric and
muscle marker genes controlling the quality of the dissections. b Comparative expression profile of the lpa receptors. c Comparative expression profile of
the s1pr genes.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02688-9 ARTICLE
COMMUNICATIONS BIOLOGY |          (2021) 4:1158 | https://doi.org/10.1038/s42003-021-02688-9 |www.nature.com/commsbio 5
Enpp4 misexpression affects expression of several components
of the RA, Notch and Wnt signalling pathways. Since retinoic
acid (RA), Notch and Wnt signalling pathways are involved in
pronephros formation and patterning25–30 and the timing of the
endogenous expression of many components of these pathways
overlap, we hypothesized that Enpp4 might affect these pathways.
We therefore examined embryos injected with enpp4 mRNA
(Fig. 4a–g) or enpp4 MO1 (Fig. 4h–n) by in situ hybridization for
alterations in expression domain of representative members e.g.
ligands (Dll1, Jag1, Wnt4) receptors (Notch1) and metabolic
enzymes (Raldh1a2, Rdh10, Cyp26a1) of these three pathways
(see also Supplementary Table 3).
Enpp4 overexpression induced ectopic and enlarged raldh1a2
and rdh10 expression domains in the pronephric region
(p < 0.001, n= 37 and 34, respectively, Fig. 4a, b and Supple-
mentary Table 3). Enpp4 knock-down reduced their expression in
pronephric region of ~20% of analysed embryos but this
phenotype is not significant (p > 0.05, n= 33 for each probe,
Fig. 4h, i and Supplementary Table 3). Raldh1a2 expression was
unaffected in the pharyngeal arches. In contrast, cyp26a1
expression was normal in the pronephric region following enpp4
mRNA or MO injection (98%, n= 44 and 88%, n= 42, p > 0.05,
respectively) (Fig. 4c, j). Both enpp4 mRNA and MO injection
disturbed rdh10 and cyp26a1 expression in the somites. These
results suggest Enpp4 controls the expression of enzymes
involved in RA synthesis and potentially might act upstream of
RA signalling. To verify this, enpp4 expression, along with pax8
and lhx1, was analysed in animal caps. Enpp4 expression is not
induced in animal caps treated with RA for 3 h (Supplementary
Fig. 4). This confirms the epistatic relationship between Enpp4
and RA signalling.
Enpp4 overexpression revealed significant enlarged expression
domains of notch1 (53% n= 75, p < 0.001, Fig. 4d). Notch1
expression was normal in the majority of embryos after enpp4
knock-down (80%, n= 41, Fig. 4k). Enpp4 mRNA injection
caused ectopic (40%) and enlarged (23%) expression domains of
dll1 (n= 81, p < 0.001 Fig. 4e), while MO-injected embryos
showed dll1 reduced expression (33%, n= 46, Fig. 4l). Ectopic
(20%) and enlarged (44%) jag1 expression domains were
observed following Enpp4 overexpression (n= 81, p < 0.001,
Fig. 4f), while MO1 injection reduced its expression domain (in
38% of the analysed embryos, n= 42, Fig. 4m). These results
suggest that Enpp4 also regulates members of the Notch
signalling pathway and that jag1 expression is more affected by
enpp4 depletion than dll1 expression. Since Rnfg overexpression
caused ectopic pronephroi formation28, we further addressed the
link between Enpp4 and the Notch pathway by injecting enpp4
mRNA or MO2 in presence of rfngmRNA or MO. Our data show
that modulation of notch-ligand interactions by Fringe proteins
alters Enpp4 pronephric phenotypes, although differences are not
significant (Supplementary Fig. 5 and Supplementary Table 3).
Finally, enpp4 mRNA injected embryos showed enlarged (32%)
and ectopic (17%) wnt4 expression domains (n= 41, Fig. 4g)
while expression of wnt4 was reduced in most of the enpp4 MO1
injected embryos (82%, n= 39, p < 0.001 Fig. 4n, Supplementary
Table 3). These data suggest that Enpp4 is necessary and
sufficient for promoting pronephric wnt4 expression.
Xenopus Enpp4 is localized to the plasma membrane. To
address the cellular localization of the amphibian Enpp4 protein,
we generated a specific polyclonal antibody against the full-length
Xenopus protein (see Supplementary Table 4 for specificity eva-
luation of the antibody) and expressed Xenopus wild type (WT),
T72S mutant and mouse Enpp4 cDNA in CHO cells by transient
transfection. Xenopus Enpp4 WT protein was detected, by wes-
tern blotting, in whole cells and in the membrane fractions, but
not in the soluble fractions (Fig. 5a). Immunofluorescence
experiments confirmed Enpp4 expression at the cell membrane
(Fig. 5b). These results show that Xenopus Enpp4 is a trans-
membrane protein, as its mouse ortholog31. Unfortunately, we
failed to detect the endogenous Enpp4 expression in Xenopus
embryos using the anti-XlEnpp4 antibody.
Fig. 4 Microinjection of enpp4 mRNA and MO affect the expression of retinoic acid synthesis enzymes, notch and wnt signalling molecules. a–g
Embryos targeted with 2 ng of enpp4 and 250 pg of LacZmRNA or h–n 10 ng of enpp4MO1 and 250 pg of LacZmRNA were fixed at stage 28 and examined
by whole-mount in situ hybridization with the following probes: raldh1a2 (a, h), rdh10 (b, i), cyp26a1 (c, j), notch1 (d, k), dll1 (e, l), jag1 (f, m) and wnt4 (g, n).
The asterisks denote the control, uninjected sides. Arrowheads indicate ectopic staining of the marker gene (see also Supplementary Table 3 and
Supplementary Fig. 4).
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Phospholipid receptors are expressed in the developing pro-
nephros along with the enpp4 gene. Based on sequence
homology of Xenopus Enpp family16, Enpp4 is more related to
lipid-hydrolysing Enpp6 and 7 enzymes. We therefore hypothe-
sized that the roles of transmembrane-bound Enpp4 during
pronephrogenesis might be linked to the lipidic signalling path-
way. To test if phospholipid receptors might mediate Enpp4
functions, we established the expression profiles of lpa and s1p
receptor family members previously identified32 by RT-PCR in
kidney dissected tissues (Fig. 3b, c). All lpa receptors, except lpar3
and 5, are expressed in pronephric tissues at a similar level from
the time of kidney specification to late differentiation, confirming
their ubiquitous expression profile during Xenopus
embryogenesis32. The s1p receptors display different expression
profiles, with s1pr5 being the only family member to be expressed
in the developing kidney at every stage analysed, particularly in
the presumptive pronephric tissue at stage 12.5. No such renal
expression was detected by in situ hybridization in our previous
study, although expression in marginal zone of blastula embryos
was detected by RT-PCR32. These data suggest that the pro-
nephric level of expression of these lipidic receptors, especially
s1pr5, is relatively low, under the in situ hybridization
detection level.
Overexpression of s1pr5 enhances Enpp4 function to induce
ectopic pronephros. In order to identify whether a lipidic
receptor is involved in Enpp4 phenotypes, s1pr and lpar over-
expression analyses were carried out by injecting 2 ng of s1pr5,
s1pr1, lpa1.1 and p2y10 mRNAs alone or in combination with
1 ng of enpp4 mRNA alone (Fig. 6a–d; Supplementary Fig. 6a–f;
Supplementary Table 5) i.e half of the optimal dose to generate
ectopic pronephros, see Fig.1). At 1 ng enpp4 mRNA dose ectopic
3G8 (7%) and 4A6 (5%) staining were obtained only in rare cases
(n= 94, Fig. 6d) compared to the optimized dose of enpp4mRNA
used in Fig. 1. Injection of any tested lipidic receptor
mRNA alone does not induce any ectopic kidney formation with
normal 3G8 and 4A6 staining in the majority of the embryos
(n= 52, Fig. 6c, Fig. S6b, d, f). Only co-expression of s1pr5
and enpp4 mRNAs resulted significantly in higher ectopic
3G8 staining compared to enpp4 mRNA alone (38%, n= 89,
p < 0.001, Fig. 6a, b, Supplementary Fig. 6a, c, e and Supple-
mentary Table 5). Furthermore, the size and frequency of the
ectopic pronephroi were higher than with injections of 2 ng of
enpp4 alone (see Fig. 1b–e). These results indicate that, among the
tested receptors, only S1pr5 enhanced Enpp4 function to generate
ectopic pronephros.
The functions of Enpp4 are mediated by the lipidic S1pr5
receptor. To further confirm that S1pr5 is involved in pronephros
development we performed loss of function experiments. Two
s1pr5 genes are identified in X.laevis genome and s1pr5.L corre-
sponds to our published sequence32. Despite distinct spatial
expression in the adult frog, the two s1pr5 homeologs display a
very similar expression profile during X.laevis embryogenesis and
are both expressed in the pronephric tissues (Supplementary
Fig. 7a, b). We therefore performed loss of function analyses with
an anti-sense MO against Xenopus s1pr5.L and s1pr5.S (see
Supplementary Figs. 6g, h and 7c, d for MOs efficiency and
specificity evaluation and Supplementary Table 5 for raw data
and statistical analyses). Embryos injected with 15 ng of s1pr5.L
MO or s1pr5.S MO displayed significant reduced 3G8 and
4A6 staining (n= 43 and 66, respectively, Fig. 6e, f, Supple-
mentary Fig. 7e and Supplementary Table 5) suggesting that
S1pr5 receptors are required for normal pronephros formation in
Xenopus.
To examine potential synergistic effects, we co-injected 7.5 ng
of s1pr5.L MO with 5 ng of enpp4 MO (half of the dose used
previously for single injections) and compared their phenotype to
those obtained following co-injection of s1pr5 MO or enpp4 MO
with control MO (Fig. 6g–j). As expected, embryos co-injected
with s1pr5.L and enpp4 MOs generated the strongest phenotype
and smallest pronephros, with strong reduction of 3G8 (74%) and
4A6 (81%) staining domains (n= 42, Fig. 6g, h). Enpp4MO alone
also caused strongly reduced 3G8 (65%) and 4A6 (60%) staining
as previously shown (n= 40, Fig. 6j), while the s1pr5.L MO alone
reduced pronephric size in both 3G8 (22%) and 4A6 (29%)
domains less frequently (n= 51, Fig. 6l). Although there are no
significant differences in pronephric phenotype between enpp4
MO1+ s1pr5.L MOs and enpp4 MO1 injected embryos, we
concluded that co-injection of s1pr5.L and enpp4 MOs showed
additive effects on the inhibition of Xenopus pronephros
development based on the size of the scored pronephroi.
To further analyse the link between Enpp4 and S1pr5, we
carried out injection of 2 ng of enpp4 mRNA together with 15 ng
of s1pr5.L MO (Fig. 6k–l) or control MO. As expected, injection
of s1pr5.L MO lowered the percentage of embryos displaying
Fig. 5 Enpp4 is a transmembrane ectonucleotidase. a CHO cells were
transfected with Xlenpp4-pcDNA3.1 or empty vector (control) and the
cellular distribution of Enpp4 determined by western blotting using anti-
XlEnpp4 antibody and proteins extracts from membrane (mb), soluble (sb)
or whole cells (wh) fractions. b Representative images of the cellular
distribution of Enpp4 determined by immunofluorescence using anti-
XlEnpp4 or anti-mEnpp4 antibodies from CHO cells transfected with
Xlenpp4-pcDNA3.1, Xlenpp4T72S-pcDNA3.1, mEnpp4-pcDNA3.1 or empty
pcDNA3.1 vector (control). Corresponding brightfield images are also
presented. Scale bar represents 20 µm.
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ectopic 3G8 and 4A6 staining caused by enpp4 mRNA injection
(17.5% and 0%, respectively, n= 40, Fig. 6k; compared to 48%
and 10%, n= 50, Fig. 6l). Furthermore, the size and number per
embryos of these ectopic pronephroi was lower than with
injection of 2 ng of enpp4 and 15 ng of cMO. Moreover, the
percentage of embryos injected with enpp4 mRNA and s1pr5.L
MO displaying a reduced 3G8 and 4A6 expression domain
remains high (42.5% and 30%, respectively, n= 40, Fig. 6k), most
certainly due to the loss of function of S1pr5.
These results indicate that the ectopic pronephric tissues
induced by Enpp4 overexpression are due to the activation of the
S1pr5 receptor.
Enpp4 specifically interacts with the lysophospholipid phos-
phatidylserine. To assess if Enpp4 hydrolyses lipids and generates a
ligand, which could bind to the S1pr5 receptor, phospholipid binding
was tested by a protein-lipid overlay assay using commercial pre-
spotted lipid membranes. Out of the 26 bioactive lipids tested, only
phosphatidylserine (PS) is specifically bound by Xenopus Enpp4
(Fig. 7a, b and Supplementary Fig. 8). Moreover, this interaction is
abolished when the putative catalytic site is mutated (Fig. 7c). We
then tried to determine the enzymatic activity of Xenopus Enpp4.
However, we could not detect any lipid derivatives, e.g. DAG, PA or
LysoPS, which could be generated from the hydrolysis of PS in the
membrane proteins fractions from overexpressing Enpp4 CHO cells.
Taken together, these data show Enpp4 specifically interacts with PS
but does not have PLA, PLC or PLD activity towards PS.
Discussion
This paper reports newly identified and unexpected roles of the
conserved ectonucleotidase Enpp4 during vertebrate kidney
development. Moreover, our findings provide a novel molecular
mechanistic understanding for pronephric development and
emphasizes the importance of the lipidic pathways in kidney
formation (Fig. 8).
We previously showed that enpp4 is expressed in pronephric
tubules16, but our present data demonstrate that low but sig-
nificant levels of enpp4 can be detected at the time of proximal
tubule specification33. Weak enpp4 expression was previously
detected by RT-PCR but not by ISH, in gastrula embryo16. This
discrepancy is attributable to the lower sensitivity of ISH com-
pared to RT-PCR for the detection of gene expression patterns.
Our work demonstrates that Enpp4 regulates the expression
level of two of the transcription factors involved in pronephric
anlagen formation, lhx1 and pax823 but not irx124. However,
induction of lhx1 ectopic expression is delayed compared to pax8
one. Such a distinct expression regulation of these two pronephric
genes by several signalling pathways has already been
described34,35. As Lhx1 is necessary for the early patterning of the
Fig. 6 Enpp4 pronephric functions are mediated by the S1pr5 receptor. Injected embryos were examined by 3G8/4A6 antibody staining following a, b
double targeted injection of 2 ng s1pr5.l mRNA and 1 ng of enpp4 mRNA, c single targeted injection of s1pr5.l, d enpp4 mRNA or e, f embryos injected with
15 ng of s1pr5.L MO. g, h Double targeted injection of 7.5 ng of s1pr5.L MO and 5 ng of enpp4 MO1. i, j Single targeted injection of s1pr5.L MO (i) or enpp4
MO1 (j). k, l Double targeted injection of 15 ng of s1pr5.L MO and 2 ng of enpp4 mRNA (k) and 15 ng of cMO and 2 ng of enpp4 mRNA (l). An asterisk
denotes the control uninjected side. An arrowhead indicates ectopic 3G8 staining (see also Supplementary Table 5 and Supplementary Figs. 6 and 7).
Fig. 7 Enpp4 specifically binds to the lysophospholipid,
phosphatidylserine. a Membrane Lipid stripTM was incubated with
membrane protein extracts from Enpp4 overexpressing CHO cells and the
bound Enpp4 protein detected with anti-XlEnpp4 serum. b, c Nitrocellulose
membranes were spotted with increasing amount of PA or PS and
incubated with membrane protein extracts from CHO cells transfected with
enpp4-pcDNA3.1, with enpp4T72S-pcDNA3.1 or empty plasmid (control)
and the bound proteins detected with anti-XlEnpp4 serum. LPA
lysophosphatidic acid, LPC lysophosphocholine, PA phosphatidic acid, PC
phospatidylcholine, PE phosphatidylethanolamine, PS phosphatidylserine,
PtIns phosphatidylinositol, S1P shingosine-1-phosphate (see also
Supplementary Fig. 8).
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entire kidney and subsequently growth and elongation in the
development of the pronephric tubules36,37, the reduction of lhx1
expression can explain the formation of the small pronephros in
enpp4 morphants. Pax8 is necessary for the earliest steps of
pronephric development and for pronephric precursors cell
proliferation and can induce the formation of ectopic pronephric
tubules23,38. Therefore, the ectopic expression of pax8 in Enpp4
overexpressing embryos can explain the formation of ectopic
pronephroi. We also demonstrate that Enpp4 is sufficient to
generate kidney, but only from lateral mesoderm and not in
ectopic non-lateral positions. This suggests that the lateral
mesoderm must contain either the receptor or the substrate
necessary for Enpp4 function. Furthermore, the induction of
enpp4 expression in activin treated animal caps confirms the
importance of mesoderm tissues for Enpp4 pronephric functions
(see Supplementary Fig. 4).
The ectopic kidneys formed from enpp4 overexpression consist
of tubular structures and are patterned along their proximal/distal
axis. Moreover, in some rare cases, there is a complete mini-
duplication of the entire pronephros. This surprising phenotype
could be explained by the upregulation of the patterning of sig-
nalling pathway members. RA signalling is required during gas-
trulation for pronephric specification. Increased levels of RA
signalling by Enpp4 overexpression could lead to pax8 expression
activation and then to the formation of ectopic pronephroi23,25.
RA signalling is also required post-gastrulation for tubules mor-
phogenesis and its downregulation in enpp4 morphants could
explain tubules formation defects25. Subsequently, RA increase
could pattern these ectopic tubules, as it has been shown during
zebrafish pronephric nephron segmentation patterning39,40.
However, in Xenopus pronephros, RA signalling increases
expression level of distal tubules markers41. Moreover, RA sig-
nalling also regulates the expression of members of the Notch
pathway42, which can subsequently activate wnt4 expression28,
which then functions to pattern the proximal pronephros. Our
data demonstrate that Rnfg protein is involved in mediating
Enpp4 signalling, probably by its ability to modify Notch-ligand
interactions43. Therefore, we speculate that Enpp4 acts upstream
or in parallel to RA signalling and upstream of Notch and Wnt
pathways (see Fig. 8). As enpp4 expression was unchanged in
animal caps treated with RA compared to control caps, this
supports the hypothesis that Enpp4 acts upstream of the RA
pathway.
A key question is how the misexpression of Enpp4, an ecto-
nucleotidase, can alter gene expression. Phosphatidylserine
translocation across the cell membrane is a well-known indicator
of apoptosis but is also involved in physiological and develop-
mental processes44,45. Therefore, Enpp4 could bind to PS in the
extracellular space during pronephrogenesis. Enpp4 enzymatic
activity is essential for ectopic kidney formation, suggesting that
renal alterations are due to an excess or shortage of Enpp4 gen-
erated products in the extracellular space inducing cell responses
via the activation of the S1pr5 receptor. However, our data
strongly suggest that the Enpp4 kidney phenotype is not linked to
the bioactive lipids LPA or S1P. The fact that the observed kidney
phenotype might be due to a non-catalytic effect of Enpp4 might
be puzzling and unexpected, especially since Enpp6 has been
suggested to play major renal physiological role through its
enzymatic functions46. However, specific functions of other
Enpps, such as Enpp1, Enpp2 and Enpp5, have been shown to be
independent of their enzymatic activity47–50. It is therefore pos-
sible that Enpp4 does not hydrolyse PS but its interaction with PS
is necessary for the activation of Enpp4 and subsequently of
S1pr5. PS binding and conformational change mechanisms have
been demonstrated for protein kinase C activation in mammalian
kidney cells, supporting this hypothesis51. Although we were
unable to detect any of the predicted products of PS hydrolysis,
we cannot rule out that we failed to characterize Enpp4 enzymatic
Fig. 8 Proposed model of how Enpp4/S1pr5 controls pronephros patterning. a During normal pronephric development, in the extracellular space, Enpp4
binds to phosphatidylserine close to, or in its catalytic site, which can then either interact with the S1pr5 or produce a novel ligand X, able to bind to this
receptor. The activation of S1pr5 leads to the upregulation of lhx1/pax8 pronephric markers in the kidney field either by acting upstream of RA signalling
pathway or by acting directly via the ERK or calcium pathways. At later stages, RA is required for tubules morphogenesis and Notch and Wnt pathway are
involved in the patterning of the pronephric tubules. The mechanism by which S1pr5 activation directs the expression domains of these genes remains to be
confirmed. b Enpp4 and S1pr5 overexpression lead to expanded and ectopic expression domains for both the Notch and RA pathway genes and wnt4.
These changes in patterning gene expression domains induce the formation of enlarged pronephric segments and ectopic pronephric tubules.
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activity and that Enpp4 will generate a bioactive lipid, other than
S1P, which is able to bind to S1p5r, the most divergent member of
the S1pr family32. Although signalling through S1PR5 has been
poorly studied, the activation of the S1P5 receptor has been
linked to an intracellular calcium increase and inactivation of the
ERK pathway, both pathways regulating pronephric field for-
mation via RA signalling35,52–55.
We show that mouse Enpp4 can fulfil Xenopus Enpp4 func-
tions during pronephrogenesis, suggesting mammalian kidney
formation may be regulated by a similar mechanism demon-
strated in this work. ENPP4 is highly expressed in human
metanephros and kidney tumours and its expression increases in
deceased donor kidney biopsies with delayed graft function after
kidney transplantation (data from human protein atlas)56.
Interestingly, ENPP4 is localized close to RUNX2 gene, whose
mutations cause cleidocranial dysplasia (CCD)57,58. Furthermore,
a child with CCD and crossed renal ectopia has been reported,
and given our data, we can speculate that the ectopic kidney is
attributable to ENPP4 locus alterations59.
We propose a potentially novel model of action of the lipidic
pathway in kidney physiology, implicating either bioactive lipids
distinct from LPA and S1P molecules or a novel non-catalytic
interaction. The fact that a S1P receptor might be activated other
than by S1P binding may explain the controversy regarding the
beneficial actions of FTY720 in renal pathologies60. Moreover,
our study raises potentially fascinating possibilities regarding
regenerative therapies for renal diseases. As therapies for chronic
renal failure are still lacking, the identification of a novel pathway
enabling the generation of ectopic kidneys may provide useful
insights to therapeutics that enhance human renal regeneration.
Methods
Ethics statement. The work was carried out under a UK Home Office-approved
animal procedures project license and approved by the University of Warwick
Biological Ethics Committee.
Enpp4 cloning and site-directed mutagenesis. The Xenopus enpp4 cDNA
(Accession number: BC 079717) was cloned into pcDNA3.1. Mouse Enpp4 cDNA
(Accession number: BC027749) was cloned into pCS2+ and pcDNA3.1. Site-directed
mutagenesis of Xenopus enpp4 was performed using a PCR-based approach. For each
mutant, 2 successive rounds of PCR were carried out using the Pfx polymerase (Invi-
trogen) following the manufacturer’s protocol and using the primers listed below. The
first round of PCR, performed using the enpp4-pRNA3 plasmid as template, allowed
the amplification of two fragments of the enpp4 coding region, one upstream and
containing the desired mutation (underscored in the primer sequence) and the other
downstream and containing the mutation, respectively. For this, one amplification was
performed using the upstream primer carrying out the mutation and the primer ORF
downstream containing the stop codon and the other amplification using the down-
stream primer carrying out the mutation and the primer ORF upstream containing the
ATG codon. The two PCR products were then mixed and a third PCR was carried out
using this mixture as template using the upstream and downstream ORF primers,
carrying out the BamHI and EcoRI restriction sites, respectively (in italic in the primer
sequence). The final PCR product was digested by BamHI and EcoRI and inserted into
the pCS2+ vector. The presence of the correct mutation was confirmed by sequencing
for each mutant. The mutant enpp4 cDNA was then extracted from the pCS2+ and
cloned into the pcDNA3.1. All constructs were verified by sequencing.
mRNA synthesis and morpholino oligonucleotides. Capped mRNAs were syn-
thesized using mMESSAGE mMACHINE Kits (Ambion) from linearized plasmids.
Plasmids used were Xenopus enpp4-pRNA3 (clone BC079717); mouse Enpp4-
pCS2+; Xenopus mutant enpp4-pCS2+; Xenopus s1p5r.L-pCS2+ (clone
DC111014); Xenopus s1p1r-pCMV-Sport6 (clone BC074356); Xenopus p2y10-
pCMV-Sport6 (clone BC084356) and Xenopus rfng-pCMV-Sport628. enpp4 MO1
(5′-atgaaaacccttccaaacatcttga-3′), enpp4 MO2 (5′-gaaatgtcacacacgcagctcctat-3′),
enpp6 MO (5′-aacgtgctgtacttagccatgccac-3′), s1pr5.L MO (5′-catggtttcgtcaatcctt-
tatttc-3′), s1pr5.S MO (5′-catggttcagtcaatgctttatctc-3′), rfng MO28 and standard
control MO (cMO) were designed and supplied by GeneTools, LLC.
Embryo culture, dissection, microinjections and lineage staining. Xenopus
embryos were staged according to Faber and Nieuwkoop61. Kidney and pronephric
anlagen dissections were performed in Barth X33. Each individual sample was
injected into the lateral marginal zone of a ventral-vegetal blastomere (V2) at the
8-cell stage to target the pronephros. Pilot experiments were carried out to
determine the enpp4 and lipidic receptors mRNAs and MOs quantities to inject,
based on their abilities to alter kidney development without affecting the overall
morphology of the embryos. The rfng mRNA and MO dose was used as previously
published28. The LacZ (250 pg) mRNA was used as a lineage tracer. LacZ mRNA
was injected alone or in combination with standard MO as controls. Injected
embryos were cultured to various developmental stages, fixed in MEMFA and
stained for β-galactosidase activity (Red-Gal or X-Gal staining) to identify correctly
targeted embryos. Only embryos that had normal pronephros formation on the
uninjected side and correctly targeted β-galactosidase staining on the injected side
were scored.
Analysis of molecular marker expression in embryos. Whole-mount immu-
nohistochemistry was performed using 3G8 and 4A6 monoclonal antibodies as
previously described20. Whole-mount in situ hybridization was carried out as
previously described62. Anti-sense digoxigenin (DIG)-labelled RNA probes were
synthesized from linearized template plasmids24,28,63. Either BM purple (Roche
Applied Science) or NBT/BCIP (Roche Applied Science) or Fast Red/Napthol AS/
MX (Sigma) was used for the colour reaction. After bleaching, embryos were
photographed with a magnification of ×10 for whole stage 41 embryos, ×20 for
whole gastrula, neurula and early organogenesis stages embryos and ×32 for
pronephric region.
Acrylamide embedding, cryostat sectioning and Hoechst staining. X. laevis
embryos were embedded sectioned at 18 µm thickness and nuclear Hoechst
staining performed64.
RT-PCR. RT-PCR reactions were carried out on whole or dissected X. laevis
embryos as described previously using the housekeeping gene odc as loading
control. Quality of pronephric tissues dissections was assessed by amplification of
the kidney markers lhx1 and pax8 and of the muscle marker myf5. Amplification
conditions and primers sequences for the enpp, lpar, s1pr, lhx1 and pax8 genes have
been previously published16,32,65. Myf5 was amplified using the forward primer, 5′-
actactacagtctcccaggacaga-3′ and the reverse primer, 5′-agagtctggaatagggagggagca-
3′, with the annealing temperature of 60 °C and 29 cycles. Each sample was ana-
lyzed in two independent embryo batches.
Cell culturing and transient transfection. Chinese hamster ovary (CHO) cells
were cultured in HAMs F-12 (Gibco BRL) containing 10% foetal serum, NaHCO3
at 1.176 g/l, 2 mM of glutamine, 5 U/ml penicillin and 37.8 U/ml streptomycin
during the 48 h prior to transfection. Cells were then transfected for 24 h using the
reagent Turbofect (Fermentas) with 1 μg of the eukaryotic constructs. The trans-
fection medium was then removed and replaced with culture medium. Approxi-
mately 48 h post transfection, cells were fixed or harvested for analyses. As a
control, CHO cells were transfected with empty vector pcDNA3.1.
Anti-Enpp4 antibody production. The anti-Xl Enpp4 polyclonal antibody was
raised in rabbits by direct intramuscular injection of the Xenopus laevis wild-type
enpp4-pcDNA3.1 plasmid followed by electroporation (Aldevron, LLC, USA).
Rabbits were immunized three times, at day 0, day 28 and 56 and terminal bleed
performed at day 70.
Immunocytochemistry. Immunocytochemistry was carried out on fixed unper-
meabilized cells with polyclonal antibodies anti-XlEnpp4 used at 1/200 or anti-
mEnpp4 (CR65; see ref. 31) used at 1/400 and anti-rabbit IgG FITC (Sigma) at 1/80.
The staining was recorded using a Nikon Optiphot/ Diginet camera system.
Photographs were taken at a magnification of ×40.
Electrophoresis and western blot. Native membrane proteins were extracted
from transfected cells using the ProteoExtract® Native Membrane Protein
Extraction Kit (Calbiochem). Proteins from whole cells and from the membrane
and soluble fractions were separated on a 12% SDS-PAGE protein gel. Part of the
gel was stained with Coomassie blue and processed for mass spectrometry analysis
(Pôle Protéomique, Plateforme Génomique Fonctionnelle de Bordeaux, Université
de Bordeaux) and the other was transferred onto a PVDF membrane (Bio-Rad)
overnight at 4 °C. To limit non-specific binding, the anti-XlEnpp4 antibody was
pre-absorbed on untransfected CHO cells. The membrane was incubated overnight
at 4 °C with 1:200 dilution of Enpp4 antiserum, washed and incubated in goat anti-
rabbit IgG peroxidase secondary antibody (Sigma, dilution 1/2000) for 30 min at
20 °C. After several washes, immunoreactivity was detected by chemiluminescence
(Western lighting Chemiluminescence Reagent Plus, Perkin Elmer).
Lipid binding assay. Hydrophobic membrane pre-spotted with bioactive lipids
(ShingoStripsTM S-6000 and Membrane Lipids StripsTM S-6002; Echelon Biosciences)
were blocked 1 h at 20 °C with 1%BSA in Tris-buffered saline 0.05% Tween-20 (TBST).
All subsequent washes were performed in TBST. Blots were overlaid with proteins
extracts from membrane fractions of CHO cells transfected with enpp4-pcDNA3.1 or
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empty vector (dilution 1/30) in blocking buffer overnight at 4 °C. Membranes were
washed and incubated with pre-absorbed Enpp4 serum (dilution 1/200) for 6 h at room
temperature. After several washes, the membranes were incubated with goat anti-rabbit
IgG peroxidase secondary antibody for 30min at room temperature, washed and
developed using enhanced chemiluminescence. To confirm the observed binding,
nitrocellulose Hybond-C extra (GE Healthcare) membranes were spotted with 0 to
200 µM of PA (Sigma P-9511) or PS (Sigma P-6641) diluted into a mix of MeOH/
CHCl3/H2O (2/1/0.8, v/v). Dried membranes were then treated as described above.
Statistics and reproducibility. All experiments were repeated several times, on
different batches of embryos, and pronephric phenotypes were determined in a
commonly used way, blind-coded, by comparing the injected and uninjected
sides28. The percentages of the embryos displaying the discussed phenotypes are
given in the text in bracket along with the total number of analysed embryos. All
raw data and statistical analyses are presented in the Supplementary Tables (SI).
Each histological analysis was numbered (see Supplementary Tables 1a, 2a, 3a and
5a) and statistically pairwise compared as indicated in the Supplementary
Tables 1b, 2b, 3b and 5b. Chi-square statistical analysis could not be performed for
all comparison of experiments since the assumption was not always fulfilled.
Hence, 2×5 Fisher’s exact test was therefore used. Bonferroni multiple testing
correction was then applied to all statistical analyses. All the statistical analyses
were performed using the R statistical software Core Team R66.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors confirm that all the data supporting the findings of this study are available in
this article and its Supplementary Information files. Unedited gels and western blot are
also presented in Supplementary Figs. 8 and 9.
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